Tirzepatide
Efficacy and Safety of Tirzepatide for Weight Management
Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 440
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Tirzepatide arm | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.